Foyston Gordon & Payne Has Boosted Baxter International (BAX) Stake; INDORAMA VENTURES (INDOY) SI Increased By 120%

January 18, 2018 - By Hazel Jackson

INDORAMA VENTURES (OTCMKTS:INDOY) had an increase of 120% in short interest. INDOY’s SI was 1,100 shares in January as released by FINRA. Its up 120% from 500 shares previously. With 100 avg volume, 11 days are for INDORAMA VENTURES (OTCMKTS:INDOY)’s short sellers to cover INDOY’s short positions. It closed at $18 lastly. It is down 0.00% since January 18, 2017 and is . It has underperformed by 16.70% the S&P500.

Foyston Gordon & Payne Inc increased Baxter International Inc. (BAX) stake by 22.97% reported in 2017Q3 SEC filing. Foyston Gordon & Payne Inc acquired 37,137 shares as Baxter International Inc. (BAX)’s stock rose 15.04%. The Foyston Gordon & Payne Inc holds 198,804 shares with $12.48M value, up from 161,667 last quarter. Baxter International Inc. now has $37.70 billion valuation. The stock increased 1.47% or $1 during the last trading session, reaching $69.2. About 4.25 million shares traded or 56.93% up from the average. Baxter International Inc. (NYSE:BAX) has risen 32.55% since January 18, 2017 and is uptrending. It has outperformed by 15.85% the S&P500.

Indorama Ventures Public Company Limited, together with its subsidiaries, makes and distributes polyethylene terephthalate , purified terephthalic acid, paraxylene, isophthalic acid, ethylene oxide and ethylene glycol (EO & EG), polyester fibers and yarns, and wool products in Thailand, North America, Europe, and internationally. The company has market cap of $9.13 billion. It operates in three divisions: PET, Feedstock, and Fibers. It has a 222.22 P/E ratio. The firm produces various PET resins, including hot-fill, low and high IV, heavy metal free, plant PET, fast re-heat, general grade, and film grade products to serve carbonated soft drink, water, juice, food, alcoholic beverages, pharmaceuticals, homecare, healthcare, APET sheet, and film extrusion industries under the RAMAPET, PERFORMANCE, and Afron brands, as well as PET packaging materials, such as PET preforms, bottles, and closures.

Since August 17, 2017, it had 0 insider buys, and 4 sales for $2.16 million activity. 8,920 shares valued at $555,538 were sold by STALLKAMP THOMAS T on Tuesday, September 5. Shapazian Carole J had sold 4,020 shares worth $247,672 on Thursday, August 24. FORSYTH JOHN D had sold 9,440 shares worth $583,014. $772,363 worth of Baxter International Inc. (NYSE:BAX) was sold by Accogli Giuseppe.

Investors sentiment increased to 0.97 in Q3 2017. Its up 0.05, from 0.92 in 2017Q2. It improved, as 38 investors sold BAX shares while 300 reduced holdings. 76 funds opened positions while 253 raised stakes. 439.80 million shares or 0.96% less from 444.08 million shares in 2017Q2 were reported. Fifth Third Bancshares owns 256,668 shares. Goelzer Investment Mgmt owns 0.05% invested in Baxter International Inc. (NYSE:BAX) for 6,755 shares. Parametric Port Limited Liability has 1.67 million shares. 1832 Asset Mngmt LP has 0.07% invested in Baxter International Inc. (NYSE:BAX) for 317,305 shares. Moreover, Dorsey And Whitney Trust Ltd has 0.77% invested in Baxter International Inc. (NYSE:BAX). Dekabank Deutsche Girozentrale holds 184,850 shares or 0.09% of its portfolio. Commercial Bank Of Ny Mellon owns 4.98 million shares or 0.09% of their US portfolio. M&T Bank & Trust accumulated 125,604 shares. Tci Wealth Inc holds 2,700 shares or 0.08% of its portfolio. First Corp In reported 1,675 shares. Provise Management Group Ltd Limited Liability Company stated it has 0.07% in Baxter International Inc. (NYSE:BAX). Utah Retirement holds 91,496 shares. Winfield Assoc invested 0.02% of its portfolio in Baxter International Inc. (NYSE:BAX). Pggm Invests holds 452,032 shares. Bartlett And Ltd Liability Com has 1.5% invested in Baxter International Inc. (NYSE:BAX) for 570,979 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: